NeoPharm is a publicly traded biopharmaceutical company engaged in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. NeoPharm has built its drug development program around two proprietary technology platforms: a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid® liposomal drug delivery system. The company has advanced five drug product candidates in various stages of clinical and pre-clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis, or IPF, and asthma. NeoPharm's stock is traded over-the-counter (OTC) under the stock symbol NEOL.PK. NeoPharm's corporate office and research and development facility is located in Lake Bluff, Illinois. NeoPharm’s new management team, enlisted in March of 2007, has undertaken a concentrated plan.
View Top Employees from NeoPharm, Inc.| Website | http://www.neopharm.com |
| Revenue | $3 million |
| Employees | 30 (25 on RocketReach) |
| Address | 1850 Lakeside Dr, Waukegan, Illinois 60085, US |
| Phone | (847) 887-0800 |
| Fax | (847) 887-9281 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Web Rank | 30 Million |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular NeoPharm, Inc. employee's phone or email?
NeoPharm, Inc. Questions
The NeoPharm, Inc. annual revenue was $3 million in 2023.
25 people are employed at NeoPharm, Inc..
NeoPharm, Inc. is based in Waukegan, Illinois.
The NAICS codes for NeoPharm, Inc. are [32, 3254, 32541, 325].
The SIC codes for NeoPharm, Inc. are [28, 283, 2834].
Top NeoPharm, Inc. Employees
-
1
-
-
1
-
21
-
2
-
1
-
-
1
Related Companies
